| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |